Preoperative measurement of serum thyroglobulin to predict malignancy in thyroid nodules: A systematic review

Hormone and Metabolic Research

Volumn 4, Issue 4, 2014, Pages 247-252

  Trimboli, P ^a,b   Treglia, G ^a   Giovanella, L ^a,c  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b Piazza San Bartolomeo All'Isola 21   (Italy)

^c REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

cytology; Thy 3; thyroglobulin; thyroid cancer

Indexed keywords

THYROGLOBULIN; TUMOR MARKER; BIOLOGICAL MARKER;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; SYSTEMATIC REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; BLOOD; MEDLINE; PATHOLOGY; PREOPERATIVE CARE; THYROID TUMOR; CANCER DIAGNOSIS; CYTOLOGY; HISTOPATHOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; HUMANS; MEDLINE; PREOPERATIVE CARE; THYROGLOBULIN; THYROID NEOPLASMS; THYROID NODULE;

EID: 84925834615     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1395517     Document Type: Article

References (34)

1. Grebe SK G. Diagnosis and management of thyroid carcinoma: focus on serum thyroglobulin. Expert Rev Endocrinol Metab: 2009; 4 25 43
2. Guidelines for the management of thyroid cancer (second edition) Royal College of Physicians of London. Suffolk The Lavenham Press: 2007
3. Gharib H., Papini E., Paschke R., Duick D. S., Valcavi R., Hegedüs L., Vitti P. AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association. Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract: 2010; 16 1 43
4. Cibas E. S., Ali S. Z. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid: 2009; 19 1159 1165
5. Trimboli P., Treglia G., Guidobaldi L., Saggiorato E., Nigri G., Crescenzi A., Romanelli F., Orlandi F., Valabrega S., Sadeghi R., Giovanella L. Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis. Endocrine: 2014; 46 52 59
6. Trimboli P., Condorelli E., Catania A., Sorrenti S. Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm. Diagn Cytopathol: 2009; 37 783 785
7. Bartolazzi A., Orlandi F., Saggiorato E., Volante M., Arecco F., Rossetto R., Palestini N., Ghigo E., Papotti M., Bussolati G., Martegani M. P., Pantellini F., Carpi A., Giovagnoli M. R., Monti S., Toscano V., Sciacchitano S., Pennelli G. M., Mian C., Pelizzo M. R., Rugge M., Troncone G., Palombini L., Chiappetta G., Botti G., Vecchione A., Bellocco R. Italian Thyroid Cancer Study Group (ITCSG). Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol: 2008; 9 543 549
8. Baloch Z. W., Fleisher S., LiVolsi V. A., Gupta P. K. Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol: 2002; 26 41 44
9. Saggiorato E., Angusti T., Rosas R., Martinese M., Finessi M., Arecco F., Trevisiol E., Bergero N., Puligheddu B., Volante M., Podio V., Papotti M., Orlandi F. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med: 2009; 50 1785 1793
10. Liberati A., Altman D. G., Tetzlaff J., Mulrow C., Gotzsche P. C., Ioannidis J. P., Clarke M., Devereaux P. J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol: 2009; 62 e1 e34
11. Rinaldi S., Plummer M., Biessy C., Tsilidis K. K., Ostergaard J. N., Overvad K., Tjonneland A., Halkjaer J., Boutron-Ruault M. C., Clavel-Chapelon F., Dossus L., Kaaks R., Lukanova A., Boeing H., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Agnoli C., Tumino R., Vineis P., Panico S., Bueno-de-Mesquita H. B., Peeters P. H., Weiderpass E., Lund E., Quirós J. R., Agudo A., Molina E., Larrañaga N., Navarro C., Ardanaz E., Manjer J., Almquist M., Sandström M., Hennings J., Khaw K. T., Schmidt J., Travis R. C., Byrnes G., Scalbert A., Romieu I., Gunter M., Riboli E., Franceschi S. Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst: 2014; 106 dju097
12. Scheffler P., Forest V. I., Leboeuf R., Florea A. V., Tamilia M., Sands N. B., Hier M. P., Mlynarek A. M., Payne R. J. Serum Thyroglobulin Improves the Sensitivity of the McGill Thyroid Nodule Score for Well-Differentiated Thyroid Cancer. Thyroid: 2014; 24 852 857
13. Lee S. H., Baek J. S., Lee J. Y., Lim J. A., Cho S. Y., Lee T. H., Ku Y. H., Kim H. I., Kim M. J. Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm. Endocr Pathol: 2013; 24 177 183
14. Zimny M., Selkinski I., Blasius S., Rink T., Schroth H. J., Grünwald F. Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin. Nuklearmedizin: 2012; 51 119 124
15. Petric R., Perhavec A., Gazic B., Besic N. Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland. J Surg Oncol: 2012; 105 351 356
16. Lee E. K., Chung K. W., Min H. S., Kim T. S., Kim T. H., Ryu J. S., Jung Y. S., Kim S. K., Lee Y. J. Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci: 2012; 27 1014 1018
17. Suh I., Vriens M. R., Guerrero M. A., Griffin A., Shen W. T., Duh Q. Y., Clark O. H., Kebebew E. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg: 2010; 200 41 46
18. Sands N. B., Karls S., Rivera J., Tamilia M., Hier M. P., Black M. J., Gologan O., Payne R. J. Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer. J. Otolaryngol Head Neck Surg: 2010; 39 669 673
19. Kuru B., Gulcelik N. E., Gulcelik M. A., Dincer H. Predictive index for carcinoma of thyroid nodules and its integration with fine-needle aspiration cytology. Head Neck: 2009; 31 856 866
20. Besic N., Sesek M., Peric B., Zgajnar J., Hocevar M. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Med Sci Monit: 2008; 14 CR459 CR467
21. Strazisar B., Petric R., Sesek M., Zgajnar J., Hocevar M., Besic N. Predictive factors of carcinoma in 279 patients with Hürthle cell neoplasm of the thyroid gland. J Surg Oncol: 2010; 101 582 586
22. Guarino E., Tarantini B., Pilli T., Checchi S., Brilli L., Ciuoli C., Di Cairano G., Mazzucato P., Pacini F. Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer. Thyroid: 2005; 15 1041 1045
23. Sugino K., Ito K., Mimura T., Kameyama K., Iwasaki H., Ito K. Hürthle cell tumor of the thyroid: analysis of 188 cases. World J Surg: 2001; 25 1160 1163
24. Giovanella L., Clark P. M., Chiovato L., Duntas L., Elisei R., Feldt-Rasmussen U., Leenhardt L., Luster M., Schalin-Jäntti C., Schott M., Seregni E., Rimmele H., Smit J., Verburg F. A. Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. Eur J Endocrinol: 2014; 171 R33 R46
25. Sands N. B., Karls S., Amir A., Tamilia M., Gologan O., Rochon L., Black M. J., Hier M. P., Payne R. J. McGill Thyroid Nodule Score (MTNS): rating the risk, a novel predictive scheme for cancer risk determination. J Otolaryngol Head Neck Surg: 2011; 40 (Suppl 1) S1 S13
26. Heinzel A., Kley K., Mueller H. W., Hautzel H. A Comparison of rh-TSH and thyroid hormone withdrawal in patients with differentiated thyroid cancer: preliminary evidence for an influence of age on the subjective well-being in hypothyroidism. Horm Metab Res: 2012; 44 54 59
27. Rosario PW S., dos Santos JB N., Calsolari M. R. Follow-up of patients with low-risk papillary thyroid carcinoma and undetectable basal serum thyroglobulin after ablation measured with a sensitive assay: a prospective study. Horm Metab Res: 2013; 45 911 914
28. Trimboli P., La Torre D., Ceriani L., Condorelli E., Laurenti O., Romanelli F., Ventura C., Signore A., Valabrega S., Giovanella L. High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients? Horm and Metab Res: 2013; 45 664 668
29. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer Cooper D. S., Doherty G. M., Haugen B. R., Kloos R. T., Lee S. L., Mandel S. J., Mazzaferri E. L., McIver B., Pacini F., Schlumberger M., Sherman S. I., Steward D. L., Tuttle R. M. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid: 2009; 19 1167 1214
30. Giovanella L., Ceriani L., Treglia G. Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre. Best Pract Res Clin Endocrinol Metab: 2014; 28 507 518
31. Trimboli P., Crescenzi A. Thyroid core needle biopsy: taking stock of the situation. Endocrine: 2014; 10.1007/s12020-014-0382-z
32. Verburg F. A., Hartmann D., Grelle I., Giovanella L., Buck A. K., Reiners C. Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer. Horm Metab Res: 2013; 45 728 735
33. Verburg F. A., Grelle I., Giovanella L., Reiners C. Evaluation of the BRAHMS KRYPTOR thyroglobulin mini-recovery test in thyroid healthy subjects. Horm Metab Res: 2012; 44 555 557
34. Pazaitou-Panayiotou K., Michalakis K., Paschke R. Thyroid cancer in patients with hyperthyroidism. Horm Metab Res: 2012; 44 255 262